US 8889191
Sustained-release formulations of topiramate
granted A61KA61K31/357A61K31/7048
Quick answer
US patent 8889191 (Sustained-release formulations of topiramate) held by Supernus Pharmaceuticals, Inc. expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/357, A61K31/7048, A61K45/06, A61K47/6951